Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1152
| Despition | PAX5 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1437 | Human LINGO1 Protein (AC1437) | 5 µg | inquiry |
| ACPP-1735 | Human BEST1 Protein (AC1735) | 5 µg | inquiry |
| ACPP-1247 | GSK3 beta Blocking Peptide (AC1247) | 250 µg | inquiry |
| ACPP-1305 | Aph 1b Blocking Peptide (AC1305) | 250 µg | inquiry |
| ACPP-1717 | Mouse LIF Protein (AC1717) | 3 x 2 µg | inquiry |
| ACPP-1463 | Human BCL2L11 Protein (AC1463) | 2 µg | inquiry |
| ACPP-1242 | MC3 Receptor Blocking Peptide (AC1242) | 250 µg | inquiry |
| ACPP-1705 | Human NXPH1 Protein (AC1705) | 5 µg | inquiry |
| ACPP-1222 | ALDH1A1 Blocking Peptide (AC1222) | 250 µg | inquiry |
| ACPP-1003 | Recombinant Human NOTCH3 Protein (Fc Tag) (AC1003) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.